Radiation Oncologist @UCSDRadMed, alum of @UChicago | @Georgetown | @UICCOM | #bcsm #gyncsm #meded #globalhealth #DEIinRO
San Diego, CA
Joined August 2008
- Tweets565
- Following636
- Followers610
- Likes3.8K
Karen Tye, MD MS retweeted
Words cannot describe how profoundly sad I am to share the news of Dr. Shekinah Elmore's death this week.
Shekinah was a SPECTACULAR human with profound wisdom, an incredible generosity of spirit, & a heart of kindness that lifted us all up.
gofundme.com/f/honoring-dr-s…
Karen Tye, MD MS retweeted
Is this another site that could benefit from collaborative #radiology and #radonc target delineation?
@MichaelFarrisM1 @JPonnatapura have shown it's feasible in LA #LCSM, I look forward to testing it in #hncsm @wakeforestmed @AtriumHealthWFB
doi.org/10.1016/j.acra.2023.…
ReIGNITE: large uncertainties defining the intraprostatic tumor in conv MRI
❓ future of intraprostatic boost, PACE-B with 5a EFS 95.8% after 40Gy/5 to whole prostate
❓ high risk pts only, 84% in FLAME
@piet_ost @alison_tree @nickva1 @KerkmeijerLinda
redjournal.org/article/S0360…
Karen Tye, MD MS retweeted
From the #RedJournal, read #radonc perspectives on DEI, featuring @pre_rad @VonettaMW @ktye @IvyRadOncMD @reshmajagsi @A_CT_SimMDJD @DrMalikaSiker @GitaSuneja @NehaVapiwala @GlobalRadOnc @LiaHalaszMD @UNCRadOnc @UNC_Lineberger bit.ly/3Xd2tbv
Karen Tye, MD MS retweeted
Current Issue: Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging
buff.ly/3VLkPiv
@AllisonZhong @christinefeng @ktye @DrAsonaLui @cjkane10 @RakowPenner @TylerSbrt
#prostatecancer #MRI #openaccess #openscience
Karen Tye, MD MS retweeted
Some exciting #ROVER sessions after #ASTRO22:
- FRIDAY 11/4: 3 pm EST: Rectal Cancer: Neoadjuvant Tx Strategies
- FRIDAY 11/11: 3 pm EST @RadiumSociety ROCKET and ROVER: Out of Left Field: Exploring Alternative #radonc Career Paths
Sign up 👇
radoncvirtual.com
Karen Tye, MD MS retweeted
The Patient: Paul Hinds, now 60, is covered by United Healthcare through a COBRA plan from his former employer.
Medical Service: Two three-month Lupron Depot injections for metastatic prostate cancer.
npr.org/sections/health-shot…
Karen Tye, MD MS retweeted
From mammograms to treatment plans, we're with you every step of the way 💗
Here at the region's ONLY NCI-designated comprehensive cancer center, our breast cancer team delivers the best care and results.
Schedule a mammogram ➡️ bit.ly/3VmGXRg
#BreastCancerAwareness
Karen Tye, MD MS retweeted
Excited for the #DEIinOncology programing a the upcoming @ASTRO_org #ASTRO22 Annual Meeting.
📲Mark these #DEIinRO #HEDI events now!
🎯Register for the MASTER CLASS today!
⭐️Centering on Equity: Reflecting on Unconscious Bias, Dominant Culture & Privilege
📅 Sat, 10/22 1-3 PM
Karen Tye, MD MS retweeted
Does the timing of chemo and RT start matter for #hncsm patients treated with definitive CRT?
Our group @steberc19 @WakeRadOncRes looked at this question with our cohort (n=131) of patients treated with definitive 💉+☢️for HNSCC (mostly OP/L).
doi.org/10.1080/0284186X.202…
1/n
Karen Tye, MD MS retweeted
Congratulations to our graduates @steberc19 @AJ_Icarus @KarinaNietoMD! We’re so proud of the #radonc doctors you’ve become ☢️🧬👩🏽⚕️👨🏽⚕️
We’ll miss you! ❤️
Karen Tye, MD MS retweeted
The ARRO Equity & Inclusion Subcommittee is continuing its mentorship program for those with interests in diversity/equity/inclusion and health disparities. To become a mentor and/or mentee, join at:
docs.google.com/forms/d/e/1F…
#UIM #equity #diversity
Karen Tye, MD MS retweeted
We can't do this anymore. Firearms are the problem.
A murderer can buy a semiautomatic weapon and kill four people an hour later. I can't get Lupron approved to give a patient an hour later.
Everything is wrong and we can't do this anymore.
This Post is from an account that no longer exists. Learn more
Karen Tye, MD MS retweeted
Based on these findings and others, how would YOU prefer to review your #radonc chart rounds?
7/7
30%In-person
70%Virtual
40 votes • Final results Karen Tye, MD MS retweeted
Our recent analysis of in-person 🧑🤝🧑 versus virtual 🖥️chart rounds peer review is out in @IJROBP!
Here's a🧵to summarize our findings #Tweetorial
doi.org/10.1016/j.ijrobp.202…
1/7
Karen Tye, MD MS retweeted
Heartening to see these authors allude to our @RSNA-recognized work at @IURadOnc (with superstar @BantuDoc_2B) as motivation for their study.
pubmed.ncbi.nlm.nih.gov/3458…
Great to see more data aiding in objective evaluation of virtual vs in-person aspects of #RadOnc patient care!
This quoted post is unavailable.
Karen Tye, MD MS retweeted
Did you know Epic can generate a detailed breakdown of usage?
What I’ve learned:
👎 time spent in in-baskets >> my colleagues
🤯 Average 2.8 minutes/message (that adds up!)
👍 98% of visits closed within 1 day
😳 39% of time spent after 7PM
Add emails, texts, pages, etc…🤦♂️
Karen Tye, MD MS retweeted
Triump-T trial presented from Dr. Yashar with brachy. Adding more tools to tool kit for Breast. As the great @Sushilberiwal would say. Not one size fits all anymore in Breast. #ASTRO21 #breastsm @ASTRO_org
Karen Tye, MD MS retweeted
We’re headed to #ASTRO2021! ✈️
Looking forward to presenting our work to the #radonc community 🧠
Karen Tye, MD MS retweeted
Starting #ASTRO21 with a💥!
Honored to present updates from @ARRO_org and our vision to foster future leaders with the @ASTRO_org Board. Special thanks to @ASTRO_Chair, @ldawsonmd et al. for the opportunity and to @ChelainG and @ShaunaRadOnc their mentorship and paving the way!
